Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Nonrandomized intervention study of naloxone coprescription for primary care patients receiving long-term opioid therapy for pain.

Coffin PO, Behar E, Rowe C, et al. Nonrandomized Intervention Study of Naloxone Coprescription for Primary Care Patients Receiving Long-Term Opioid Therapy for Pain. Ann Intern Med. 2016;165(4):245-252. doi:10.7326/M15-2771.

Save
Print
September 4, 2016
Coffin PO, Behar E, Rowe C, et al. Ann Intern Med. 2016;165(4):245-252.
View more articles from the same authors.

Opioid medications carry significant risk of adverse drug events. This observational study found that patients prescribed naloxone to treat overdose in home and community settings were less likely to have opioid-related emergency department visits compared to those not prescribed naloxone. This finding demonstrates the safety benefit of prescribing naloxone in outpatients.

Save
Print
Cite
Citation

Coffin PO, Behar E, Rowe C, et al. Nonrandomized Intervention Study of Naloxone Coprescription for Primary Care Patients Receiving Long-Term Opioid Therapy for Pain. Ann Intern Med. 2016;165(4):245-252. doi:10.7326/M15-2771.